Literature DB >> 20133654

Structural insight into M-band assembly and mechanics from the titin-obscurin-like-1 complex.

Stefano Pernigo1, Atsushi Fukuzawa, Morten Bertz, Mark Holt, Matthias Rief, Roberto A Steiner, Mathias Gautel.   

Abstract

In the sarcomeric M-band, the giant ruler proteins titin and obscurin, its small homologue obscurin-like-1 (obsl1), and the myosin cross-linking protein myomesin form a ternary complex that is crucial for the function of the M-band as a mechanical link. Mutations in the last titin immunoglobulin (Ig) domain M10, which interacts with the N-terminal Ig-domains of obscurin and obsl1, lead to hereditary muscle diseases. The M10 domain is unusual not only in that it is a frequent target of disease-linked mutations, but also in that it is the only currently known muscle Ig-domain that interacts with two ligands--obscurin and obsl1--in different sarcomeric subregions. Using x-ray crystallography, we show the structural basis for titin M10 interaction with obsl1 in a novel antiparallel Ig-Ig architecture and unravel the molecular basis of titin-M10 linked myopathies. The severity of these pathologies correlates with the disruption of the titin-obsl1/obscurin complex. Conserved signature residues at the interface account for differences in affinity that direct the cellular sorting in cardiomyocytes. By engineering the interface signature residues of obsl1 to obscurin, and vice versa, their affinity for titin can be modulated similar to the native proteins. In single-molecule force-spectroscopy experiments, both complexes yield at forces of around 30 pN, much lower than those observed for the mechanically stable Z-disk complex of titin and telethonin, suggesting why even moderate weakening of the obsl1/obscurin-titin links has severe consequences for normal muscle functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133654      PMCID: PMC2814874          DOI: 10.1073/pnas.0913736107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Reverse engineering of the giant muscle protein titin.

Authors:  Hongbin Li; Wolfgang A Linke; Andres F Oberhauser; Mariano Carrion-Vazquez; Jason G Kerkvliet; Hui Lu; Piotr E Marszalek; Julio M Fernandez
Journal:  Nature       Date:  2002-08-29       Impact factor: 49.962

2.  Dimerisation of myomesin: implications for the structure of the sarcomeric M-band.

Authors:  Stephan Lange; Mirko Himmel; Daniel Auerbach; Irina Agarkova; Katrin Hayess; Dieter O Fürst; Jean-Claude Perriard; Elisabeth Ehler
Journal:  J Mol Biol       Date:  2005-01-14       Impact factor: 5.469

Review 3.  The M-band: an elastic web that crosslinks thick filaments in the center of the sarcomere.

Authors:  Irina Agarkova; Jean-Claude Perriard
Journal:  Trends Cell Biol       Date:  2005-09       Impact factor: 20.808

Review 4.  Muscle giants: molecular scaffolds in sarcomerogenesis.

Authors:  Aikaterini Kontrogianni-Konstantopoulos; Maegen A Ackermann; Amber L Bowman; Solomon V Yap; Robert J Bloch
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

5.  Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin.

Authors:  Peter Hackman; Anna Vihola; Henna Haravuori; Sylvie Marchand; Jaakko Sarparanta; Jerome De Seze; Siegfried Labeit; Christian Witt; Leena Peltonen; Isabelle Richard; Bjarne Udd
Journal:  Am J Hum Genet       Date:  2002-07-26       Impact factor: 11.025

6.  The first Italian family with tibial muscular dystrophy caused by a novel titin mutation.

Authors:  Marzia Pollazzon; Tiina Suominen; Sini Penttilä; Alessandro Malandrini; Maria Alessandra Carluccio; Mauro Mondelli; Annabella Marozza; Antonio Federico; Alessandra Renieri; Peter Hackman; Maria Teresa Dotti; Bjarne Udd
Journal:  J Neurol       Date:  2009-11-13       Impact factor: 4.849

Review 7.  Cytoplasmic Ig-domain proteins: cytoskeletal regulators with a role in human disease.

Authors:  Carol A Otey; Richard Dixon; Christianna Stack; Silvia M Goicoechea
Journal:  Cell Motil Cytoskeleton       Date:  2009-08

8.  Palindromic assembly of the giant muscle protein titin in the sarcomeric Z-disk.

Authors:  Peijian Zou; Nikos Pinotsis; Stephan Lange; Young-Hwa Song; Alexander Popov; Irene Mavridis; Olga M Mayans; Mathias Gautel; Matthias Wilmanns
Journal:  Nature       Date:  2006-01-12       Impact factor: 49.962

9.  Fisher's information in maximum-likelihood macromolecular crystallographic refinement.

Authors:  Roberto A Steiner; Andrey A Lebedev; Garib N Murshudov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-11-27

10.  C-terminal titin deletions cause a novel early-onset myopathy with fatal cardiomyopathy.

Authors:  Virginie Carmignac; Mustafa A M Salih; Susana Quijano-Roy; Sylvie Marchand; Molham M Al Rayess; Maowia M Mukhtar; Jon A Urtizberea; Siegfried Labeit; Pascale Guicheney; France Leturcq; Mathias Gautel; Michel Fardeau; Kevin P Campbell; Isabelle Richard; Brigitte Estournet; Ana Ferreiro
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

View more
  27 in total

1.  Fast-folding alpha-helices as reversible strain absorbers in the muscle protein myomesin.

Authors:  Felix Berkemeier; Morten Bertz; Senbo Xiao; Nikos Pinotsis; Matthias Wilmanns; Frauke Gräter; Matthias Rief
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

2.  Solution NMR structures of immunoglobulin-like domains 7 and 12 from obscurin-like protein 1 contribute to the structural coverage of the Human Cancer Protein Interaction Network.

Authors:  Surya V S R K Pulavarti; Yuanpeng J Huang; Kari Pederson; Thomas B Acton; Rong Xiao; John K Everett; James H Prestegard; Gaetano T Montelione; Thomas Szyperski
Journal:  J Struct Funct Genomics       Date:  2014-07-03

3.  β-Arrestin mediates the Frank-Starling mechanism of cardiac contractility.

Authors:  Dennis M Abraham; Robert T Davis; Chad M Warren; Lan Mao; Beata M Wolska; R John Solaro; Howard A Rockman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

4.  Exercise-induced alterations and loss of sarcomeric M-line organization in the diaphragm muscle of obscurin knockout mice.

Authors:  D Randazzo; B Blaauw; C Paolini; E Pierantozzi; S Spinozzi; S Lange; J Chen; F Protasi; C Reggiani; V Sorrentino
Journal:  Am J Physiol Cell Physiol       Date:  2016-10-26       Impact factor: 4.249

5.  α-Actinin/titin interaction: A dynamic and mechanically stable cluster of bonds in the muscle Z-disk.

Authors:  Marco Grison; Ulrich Merkel; Julius Kostan; Kristina Djinović-Carugo; Matthias Rief
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

6.  Real-time visualization of titin dynamics reveals extensive reversible photobleaching in human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Adrian G Cadar; Tromondae K Feaster; Kevin R Bersell; Lili Wang; TingTing Hong; Joseph A Balsamo; Zhentao Zhang; Young Wook Chun; Young-Jae Nam; Michael Gotthardt; Björn C Knollmann; Dan M Roden; Chee C Lim; Charles C Hong
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-20       Impact factor: 4.249

7.  Biophysical characterization of naturally occurring titin M10 mutations.

Authors:  Michael W Rudloff; Alec N Woosley; Nathan T Wright
Journal:  Protein Sci       Date:  2015-04-02       Impact factor: 6.725

8.  Titin and obscurin: giants holding hands and discovery of a new Ig domain subset.

Authors:  Guy M Benian; Olga Mayans
Journal:  J Mol Biol       Date:  2014-12-31       Impact factor: 5.469

Review 9.  The giant protein titin: a regulatory node that integrates myocyte signaling pathways.

Authors:  Martina Krüger; Wolfgang A Linke
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

10.  Obscurin is a semi-flexible molecule in solution.

Authors:  Jacob A Whitley; Aidan M Ex-Willey; Daniel R Marzolf; Maegen A Ackermann; Anthony L Tongen; Oleksandr Kokhan; Nathan T Wright
Journal:  Protein Sci       Date:  2019-02-06       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.